Decellularization of Wharton's Jelly Increases Its Bioactivity and Antibacterial Properties.
Fiche publication
Date publication
janvier 2022
Journal
Frontiers in bioengineering and biotechnology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr GANGLOFF Sophie, Dr TERRYN Christine, Dr KERDJOUDJ Halima, Dr GINDRAUX Florelle
Tous les auteurs :
Dubus M, Scomazzon L, Chevrier J, Montanede A, Baldit A, Terryn C, Quilès F, Thomachot-Schneider C, Gangloff SC, Bouland N, Gindraux F, Rammal H, Mauprivez C, Kerdjoudj H
Lien Pubmed
Résumé
The field of regenerative medicine has recently seen an emerging trend toward decellularized extracellular matrix (ECM) as a biological scaffold for stem cell-delivery. Human umbilical cord represents a valuable opportunity from both technical and ethical point of view to obtain allogenic ECM. Herein, we established a protocol, allowing the full removal of cell membranes and nuclei moieties from Wharton's jelly (WJ) tissue. No alterations in the ECM components ( collagen, GAG content, and growth factors), physical ( porosity and swelling) and mechanical ( linear tensile modulus) properties were noticed following WJ processing. Furthermore, no effect of the tissue processing on macromolecules and growth factors retention was observed, assuring thus a suitable bioactive matrix for cell maintenance upon recellularization. Based on the and biodegradability and stromal cell homing capabilities, decellularized WJ could provide an ideal substrate for stromal cells adhesion and colonization. Interestingly, the tissue processing increased the antibacterial and antiadhesive properties of WJ against and pathogens. Altogether, our results indicate that decellularized WJ matrix is able to limit Staphylococcus-related infections and to promote stromal cell homing, thus offering a versatile scaffold for tissue regenerative medicine.
Mots clés
Wharton’s jelly, antibacterial, bioactivity, biocompatibility, decellularization, in vivo
Référence
Front Bioeng Biotechnol. 2022 ;10:828424